nifedipine has been researched along with Angiospasm, Intracranial in 5 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Magnesium sulfate may prevent eclampsia by reducing cerebral vasoconstriction and ischemia." | 9.10 | A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. ( Allen, JC; Anthony, J; Belfort, MA; Saade, GR, 2003) |
| "Magnesium sulfate may prevent eclampsia by reducing cerebral vasoconstriction and ischemia." | 5.10 | A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. ( Allen, JC; Anthony, J; Belfort, MA; Saade, GR, 2003) |
| "Cerebral aneurysm rupture and subarachnoid hemorrhage (SAH) inflict disability and death on thousands of individuals each year." | 1.33 | Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage. ( Honda, A; Ishiguro, M; Russell, SR; Tranmer, BI; Wellman, GC; Wellman, TL, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bain, J | 1 |
| Segal, D | 1 |
| Amin, R | 1 |
| Monoky, D | 1 |
| Thompson, SJ | 1 |
| Pitkänen, H | 1 |
| Saarela, V | 1 |
| Fernández-Tenorio, M | 1 |
| Porras-González, C | 1 |
| Castellano, A | 1 |
| Del Valle-Rodríguez, A | 1 |
| López-Barneo, J | 1 |
| Ureña, J | 1 |
| Belfort, MA | 1 |
| Anthony, J | 1 |
| Saade, GR | 1 |
| Allen, JC | 1 |
| Ishiguro, M | 1 |
| Wellman, TL | 1 |
| Honda, A | 1 |
| Russell, SR | 1 |
| Tranmer, BI | 1 |
| Wellman, GC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial (LAMPET)[NCT00293735] | Phase 2/Phase 3 | 0 participants (Actual) | Interventional | 2015-06-30 | Withdrawn (stopped due to Lack of funding) | ||
| A Novel Protocol for Postpartum Magnesium Sulfate in Severe Preeclampsia When the Woman Received Less That 8 Hours Before Delivery. Six Versus Twenty-four Hours Postpartum[NCT02317146] | Phase 2/Phase 3 | 280 participants (Actual) | Interventional | 2013-11-30 | Completed | ||
| Magnesium Sulfate During the Postpartum in Women With Severe Preeclampsia Receiving Treatment for More Than 8 Hours Before Delivery. A Randomized Multicenter Clinical Trial .[NCT02307201] | Phase 2/Phase 3 | 1,114 participants (Actual) | Interventional | 2014-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for nifedipine and Angiospasm, Intracranial
| Article | Year |
|---|---|
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
Topics: Anticonvulsants; Calcium Channel Blockers; Eclampsia; Female; Humans; Logistic Models; Magnesium Sul | 2003 |
4 other studies available for nifedipine and Angiospasm, Intracranial
| Article | Year |
|---|---|
Call-Fleming syndrome: headache in a 16-year-old girl.
Topics: Adolescent; Angiography; Anxiety; Attention Deficit Disorder with Hyperactivity; Female; Headache; H | 2013 |
Vasospastic transient monocular visual loss: effect of treatment with different doses of nifedipine.
Topics: Adult; Calcium Channel Blockers; Female; Functional Laterality; Humans; Magnetic Resonance Imaging; | 2014 |
Metabotropic regulation of RhoA/Rho-associated kinase by L-type Ca2+ channels: new mechanism for depolarization-evoked mammalian arterial contraction.
Topics: Animals; Basilar Artery; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Coronary Vasos | 2011 |
Emergence of a R-type Ca2+ channel (CaV 2.3) contributes to cerebral artery constriction after subarachnoid hemorrhage.
Topics: Animals; Blood; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, R-Typ | 2005 |